Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalmefene Efficacy Study II
2007-002563-27Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in alcohol dependence and alcohol use disorder (AUD) comparing Nalmefene 20 mg as-needed with Placebo as-needed (2 arms). Primary endpoints: Monthly number of heavy drinking days and Monthly total alcohol consumption. Started Oct 2008; status: completed.
02
Drugs
nalmefene
03
Conditions
alcohol dependencealcohol use disorder (AUD)
Beyond the preview
Go deeper on 2007-002563-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002563-27.